TY - JOUR
T1 - The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis
AU - Weibell, Melissa A
AU - Hegelstad, Wenche Ten Velden
AU - Auestad, Bjørn
AU - Bramness, Jørgen
AU - Evensen, Julie
AU - Haahr, Ulrik
AU - Joa, Inge
AU - Johannessen, Jan Olav
AU - Larsen, Tor Ketil
AU - Melle, Ingrid
AU - Opjordsmoen, Stein
AU - Rund, Bjørn Rishovd
AU - Simonsen, Erik
AU - Vaglum, Per
AU - McGlashan, Thomas
AU - McGorry, Patrick
AU - Friis, Svein
N1 - © The Author 2017. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: [email protected].
PY - 2017/7/1
Y1 - 2017/7/1
N2 - Substance use is common in first-episode psychosis (FEP) and has been linked to poorer outcomes with more severe psychopathology and higher relapse rates. Early substance discontinuation appears to improve symptoms and function. However, studies vary widely in their methodology, and few have examined patients longitudinally, making it difficult to draw conclusions for practice and treatment. We aimed to investigate the relationship between substance use and early abstinence and the long-term course of illness in a representative sample of FEP patients. Out of 301 included patients, 266 could be divided into 4 groups based on substance use patterns during the first 2 years of treatment: persistent users, episodic users, stop-users and nonusers. Differences in clinical and functional measures during the follow-up period were assessed using linear mixed effects models for the analysis of repeated measures data. Patients who stopped using substances within the first 2 years after diagnosis had outcomes similar to those who had never used with fewer symptoms than episodic or persistent users. Both episodic and persistent users had lower rates of symptom remission than nonusers, and persistent users also had more negative symptoms than those who stopped using. Our findings emerge from one of very few long-term longitudinal studies examining substance use cessation in FEP with 10-year follow-up. The results convey hope that the detrimental effects of substance abuse on mental health may be significantly reversed if one stops the abuse in time. This can help patients who struggle with addiction with their motivation to embrace abstinence.
AB - Substance use is common in first-episode psychosis (FEP) and has been linked to poorer outcomes with more severe psychopathology and higher relapse rates. Early substance discontinuation appears to improve symptoms and function. However, studies vary widely in their methodology, and few have examined patients longitudinally, making it difficult to draw conclusions for practice and treatment. We aimed to investigate the relationship between substance use and early abstinence and the long-term course of illness in a representative sample of FEP patients. Out of 301 included patients, 266 could be divided into 4 groups based on substance use patterns during the first 2 years of treatment: persistent users, episodic users, stop-users and nonusers. Differences in clinical and functional measures during the follow-up period were assessed using linear mixed effects models for the analysis of repeated measures data. Patients who stopped using substances within the first 2 years after diagnosis had outcomes similar to those who had never used with fewer symptoms than episodic or persistent users. Both episodic and persistent users had lower rates of symptom remission than nonusers, and persistent users also had more negative symptoms than those who stopped using. Our findings emerge from one of very few long-term longitudinal studies examining substance use cessation in FEP with 10-year follow-up. The results convey hope that the detrimental effects of substance abuse on mental health may be significantly reversed if one stops the abuse in time. This can help patients who struggle with addiction with their motivation to embrace abstinence.
KW - Journal Article
U2 - 10.1093/schbul/sbw179
DO - 10.1093/schbul/sbw179
M3 - Journal article
C2 - 28199703
SN - 0586-7614
VL - 43
SP - 843
EP - 851
JO - Schizophrenia Bulletin
JF - Schizophrenia Bulletin
IS - 4
ER -